These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 25370187)
1. Diabetes-independent increase of factor VII-activating protease activation in patients with Gram-negative sepsis (melioidosis). de Jong HK; Koh GC; Bulder I; Stephan F; Wiersinga WJ; Zeerleder SS J Thromb Haemost; 2015 Jan; 13(1):41-6. PubMed ID: 25370187 [TBL] [Abstract][Full Text] [Related]
2. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Stephan F; Hazelzet JA; Bulder I; Boermeester MA; van Till JO; van der Poll T; Wuillemin WA; Aarden LA; Zeerleder S Crit Care; 2011; 15(2):R110. PubMed ID: 21466697 [TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease. Stephan F; Dienava-Verdoold I; Bulder I; Wouters D; Mast AE; Te Velthuis H; Aarden LA; Zeerleder S J Thromb Haemost; 2012 Jun; 10(6):1165-71. PubMed ID: 22449009 [TBL] [Abstract][Full Text] [Related]
4. Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis). Koh GC; Meijers JC; Maude RR; Limmathurotsakul D; Day NP; Peacock SJ; van der Poll T; Wiersinga WJ Thromb Haemost; 2011 Dec; 106(6):1139-48. PubMed ID: 21979378 [TBL] [Abstract][Full Text] [Related]
5. Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). Kager LM; Weehuizen TA; Wiersinga WJ; Roelofs JJ; Meijers JC; Dondorp AM; van 't Veer C; van der Poll T Am J Respir Crit Care Med; 2013 Oct; 188(8):967-75. PubMed ID: 23992406 [TBL] [Abstract][Full Text] [Related]
6. Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. Wiersinga WJ; Meijers JC; Levi M; Van 't Veer C; Day NP; Peacock SJ; van der Poll T J Thromb Haemost; 2008 Jan; 6(1):32-9. PubMed ID: 17944999 [TBL] [Abstract][Full Text] [Related]
7. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs). Grasso S; Neumann A; Lang IM; Etscheid M; von Köckritz-Blickwede M; Kanse SM Thromb Res; 2018 Jan; 161():36-42. PubMed ID: 29178989 [TBL] [Abstract][Full Text] [Related]
8. Cooperation of factor VII-activating protease and serum DNase I in the release of nucleosomes from necrotic cells. Stephan F; Marsman G; Bakker LM; Bulder I; Stavenuiter F; Aarden LA; Zeerleder S Arthritis Rheumatol; 2014 Mar; 66(3):686-93. PubMed ID: 24574229 [TBL] [Abstract][Full Text] [Related]
9. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. Kanse SM; Gallenmueller A; Zeerleder S; Stephan F; Rannou O; Denk S; Etscheid M; Lochnit G; Krueger M; Huber-Lang M J Immunol; 2012 Mar; 188(6):2858-65. PubMed ID: 22308306 [TBL] [Abstract][Full Text] [Related]
10. FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE. Marsman G; Stephan F; de Leeuw K; Bulder I; Ruinard JT; de Jong J; Westra J; Bultink IE; Voskuyl AE; Aarden LA; Luken BM; Kallenberg CG; Zeerleder S Eur J Immunol; 2016 Mar; 46(3):762-71. PubMed ID: 26626052 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the endothelial protein C receptor is detrimental during pneumonia-derived gram-negative sepsis (Melioidosis). Kager LM; Schouten M; Wiersinga WJ; de Boer JD; Lattenist LC; Roelofs JJ; Meijers JC; Levi M; Dondorp AM; Esmon CT; van 't Veer C; van der Poll T PLoS Negl Trop Dis; 2013; 7(7):e2306. PubMed ID: 23875041 [TBL] [Abstract][Full Text] [Related]
12. FSAP, a new player in inflammation? Stephan F; Aarden LA; Zeerleder S Hamostaseologie; 2012; 32(1):51-5. PubMed ID: 22252569 [TBL] [Abstract][Full Text] [Related]
13. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766 [TBL] [Abstract][Full Text] [Related]
14. Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity. Morris J; Williams N; Rush C; Govan B; Sangla K; Norton R; Ketheesan N Infect Immun; 2012 Jun; 80(6):2089-99. PubMed ID: 22473609 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Wiersinga WJ; van't Veer C; van den Pangaart PS; Dondorp AM; Day NP; Peacock SJ; van der Poll T Crit Care Med; 2009 Feb; 37(2):569-76. PubMed ID: 19114913 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis). de Jong HK; Koh GC; Achouiti A; van der Meer AJ; Bulder I; Stephan F; Roelofs JJ; Day NP; Peacock SJ; Zeerleder S; Wiersinga WJ Intensive Care Med Exp; 2014 Dec; 2(1):21. PubMed ID: 26215706 [TBL] [Abstract][Full Text] [Related]